12 January 2024
In a protocol signed yesterday, January 11th, the Champalimaud Foundation and Beneficência Portuguesa de São Paulo came together to develop innovative work in various fields of medicine.
The objective of this partnership will be focused on research and improvement of medicine dedicated to the treatment of patients with pancreatic cancer.
This collaboration will reinforce scientific exchange between the two institutions and will be led by doctors and researchers from both institutions such as Carlos Carvalho and Sherman Moreira from the Champalimaud Foundation, and Gustavo Guimarães, Bendito Rossi and Fabio Kater from Beneficência Portuguesa de São Paulo.
Beneficência Portuguesa de São Paulo is a Brazilian institution that is over 163 years old and is one of the largest healthcare hubs in South America, with 5,000 doctors and 733 beds. It serves more than 200,000 people annually and is a reference in medical and hospital care in various specialties, with emphasis on Cardiology, Oncology and Neurology, with an infrastructure that brings together complementary diagnostic and therapeutic medicine services, consultations, exams, education and research.
